Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
Could a painkiller improve breathing in lung scarring?
Symptom relief Recruiting nowThis early-stage study is testing a drug called nalbuphine ER in 10 adults with idiopathic pulmonary fibrosis (IPF), a lung-scarring disease that makes breathing hard. The goal is to see if the drug is safe and can improve breathing function. Participants will take increasing dos…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated May 04, 2026 16:31 UTC
-
Breakfast may change how this pain drug works
Knowledge-focused Recruiting nowThis study looks at how a high-fat, high-calorie meal changes the way the body absorbs nalbuphine extended-release tablets. Sixty healthy adults will take the drug once with food and once without, and researchers will compare the levels in their blood. The goal is to understand i…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC